Decipher cost per test
Active Awarded Last action
- Contract number
- 36C24826N0322
- Awardee
-
Veracyte Labs SD Corporation UEI DKKCNLTYT2A1 Part of Veracyte, Inc.
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $194,435
Award facts
- Contract value 100% obligated
- $194,435.40 Current and potential, with all options
- Completion date 75% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
Veracyte Labs SD Corporation, operating under its Decipher Biosciences division, was awarded a Blanket Purchase Agreement call valued at $194,435.40 by Veterans Integrated Service Network 8 on February 1, 2026, with performance completion by January 31, 2027. This firm fixed-price contract, which carries no set-aside designation, establishes a cost-per-test pricing structure for Decipher Prostate Cancer genomic testing services to be performed in San Diego, California. The contract operates under the General Services Administration's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and supports the Department of Veterans Affairs' precision medicine initiatives for prostate cancer diagnosis and treatment planning across veteran healthcare networks.
Veracyte Labs SD Corporation specializes in advanced genomic testing and molecular diagnostic services, with the Decipher Prostate Cancer Test serving as its primary offering for federal healthcare agencies. The company analyzes tumor gene expression patterns to assess cancer risk, aggressiveness, and metastatic potential, enabling clinicians to make informed treatment decisions. This award represents one of multiple delivery orders and blanket purchase agreements the company has received from various Veterans Integrated Service Networks and the Defense Health Agency, with the parent company Veracyte, Inc., headquartered in South San Francisco, maintaining an extensive federal contract portfolio spanning multiple genomic testing applications including thyroid and prostate cancer diagnostics.
Quick answers
Who was awarded contract 36C24826N0322?
36C24826N0322 was awarded to Veracyte Labs SD Corporation by Veterans Integrated Service Network 8 (Veterans Health Administration) on February 1, 2026.
How much is contract 36C24826N0322 worth?
The government has obligated $194,435 on 36C24826N0322.
Is contract 36C24826N0322 an order under another contract?
Yes. 36C24826N0322 is a BPA call under 36F79721D0019-36C24823A0010, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C24826N0322 competed?
The extent of competition for 36C24826N0322 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award